Tag: Mene Pangalos

AstraZeneca to acquire US biopharma company CinCor Pharma for $1.8bn

Raghuram Kadari- January 10, 2023

AstraZeneca has agreed to acquire CinCor Pharma for a transaction value of around $1.8 billion, which includes an upfront cash payment of about $1.3 billion, ... Read More

AstraZeneca and Imperial spin-off VaxEquity enter into saRNA partnership

pallavi123- September 26, 2021

AstraZeneca has signed a collaboration deal with VaxEquity, a spin-off of Imperial College London, for discovering, developing, and commercializing the latter’s self-amplifying RNA (saRNA) therapeutics ... Read More

AstraZeneca scores Chinese approval for heart failure therapy Forxiga

pharmanewsdaily- February 7, 2021

AstraZeneca said that Forxiga (dapagliflozin) has secured approval in China for its use in the reduction of the risk of cardiovascular (CV) death and hospitalization ... Read More

AstraZeneca gets BRILINTA FDA approval for reducing risk of stroke in acute ischemic stroke or high-risk transient ischemic attack

pharmanewsdaily- November 8, 2020

BRILINTA FDA approval : AstraZeneca has bagged approval for BRILINTA (ticagrelor) from the US  Food and Drug Administration for its use in reducing the risk ... Read More

AstraZeneca gets FDA breakthrough status for Farxiga in CKD

pharmanewsdaily- October 4, 2020

AstraZeneca has been granted breakthrough therapy designation (BTD) for Farxiga (dapagliflozin) from the US Food and Drug Administration (FDA) for the treatment of patients with ... Read More

AstraZeneca acquires oral PCSK9 inhibitors from Dogma Therapeutics

pharmanewsdaily- September 19, 2020

Pharma giant AstraZeneca has signed a deal to acquire a preclinical oral PCSK9 inhibitor asset from Dogma Therapeutics, a portfolio company of Viva Biotech. The ... Read More

COV001 clinical trial results : Oxford vaccine ChAdOx1 nCoV-19 triggers strong immune response

pharmanewsdaily- July 20, 2020

COV001 clinical trial results : AstraZeneca and Oxford University said that interim results from the phase 1/2 COV001 clinical trial showed the ChAdOx1 nCoV-19 vaccine ... Read More

Farxiga : AstraZeneca gets FDA fast track status for heart failure after MI

pharmanewsdaily- July 20, 2020

AstraZeneca has secured fast track designation for Farxiga (dapagliflozin) in the US for its use in reducing the risk of hospitalization for heart failure (hHF) ... Read More

Allergan to sell brazikumab to AstraZeneca and Zenpep to Nestle

pharmanewsdaily- January 27, 2020

Allergan has agreed to sell IL-23 inhibitor brazikumab to AstraZeneca and gastrointestinal medication Zenpep (pancrelipase) to Nestle in separate agreements, as per the latest pharma ... Read More